Executives in the story were asked nine questions.
We asked the executives the following 9 questions. The surprise was how generous and forthcoming they were with their answers. We only wish we had more space so we could have printed everything they had to share. Instead, we culled the most cogent and timely of their comments and put together a kind of "Facebook." We believe it makes for interesting reading as well as being a useful guide to what the thinking is behind the agency you might be considering.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.